The dimensions of white matter injury in preterm neonates

Mireille Guillot1, Steven P Miller2

  • 1Department of Pediatrics (Neurology), University of Toronto and the Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Toronto M5G 1X8, Canada; Department of Pediatrics (Neonatology), Université Laval and Centre Hospitalier Universitaire de Québec, Québec, Canada.

Seminars in Perinatology
|August 30, 2021
PubMed

Insights

White matter injury (WMI) in preterm neonates is common and linked to adverse neurodevelopmental outcomes. Understanding WMI

Area of Science:

  • Neonatal neurology
  • Neuroimaging
  • Developmental neuroscience

Background:

  • White matter injury (WMI) is a common brain injury in preterm neonates.
  • WMI involves destructive and maturational anomalies, primarily caused by hypoxia-ischemia affecting oligodendrocyte precursor cells.
  • Inflammation can potentiate WMI, often co-occurring with comorbidities like infections, NEC, and bronchopulmonary dysplasia.

Purpose of the Study:

  • To review the pathophysiology and imaging diagnosis of WMI in preterm neonates.
  • To explore the link between postnatal complications and WMI.
  • To guide the interpretation of white matter anomalies for predicting neurodevelopmental outcomes.

Main Methods:

  • This is a review article, synthesizing existing literature.
  • Focuses on the mechanisms of WMI, including hypoxia-ischemia and inflammation.
  • Discusses neuroimaging techniques for diagnosing and characterizing WMI.

Main Results:

  • Hypoxia-ischemia is the primary cause of WMI, impacting oligodendrocyte precursor cells.
  • Inflammation acts as a potentiator, frequently associated with neonatal comorbidities.
  • Detailed imaging characterization of WMI aids in predicting neurodevelopmental outcomes.

Conclusions:

  • WMI is a significant predictor of adverse neurodevelopmental outcomes in preterm infants.
  • Accurate diagnosis and characterization of WMI through imaging are crucial.
  • Understanding the interplay of hypoxia-ischemia, inflammation, and comorbidities is key to managing WMI.

Related Concept Videos